摘要
背景:微剂量锂对阿尔茨海默病(AD)有保护作用,但其保护作用的确切机制尚不清楚。 目的:为了进一步研究Aβ早期病理过程中的作用,我们评价了微量锂制剂NP 03是否对Aβ介导的氧化损伤和神经感染有调节作用。应用于高表达淀粉样前体蛋白(APP)的AD样淀粉样变转基因大鼠模型。 方法:将转基因大鼠和野生型白蚁用NP 03或载体制剂治疗8周,从3个月开始,在t期出现β斑块沉积前的一个阶段。转基因老鼠。 结果:氧化和亚硝基应激标记物、蛋白质结合的4-羟基壬烯醛(Hne)和蛋白-3-硝基酪氨酸(3-nt)、炎性细胞因子的产生以及小胶质细胞的合成。对β负荷神经元进行检测。NP 03能显著降低McGill-R-Thy1-app转基因大鼠脑内HNE和3-NT的含量,减少促炎细胞因子的产生。NP 03进一步r诱导海马CA1区小胶质细胞表面受体TREM 2的表达,导致海马CA1区小胶质细胞向β负荷神经元的募集相应减少。 结论:NP 03可能通过改善氧化/亚硝基损伤和神经炎症而延缓AD样病变,增加了低剂量o的可能性。F微囊化锂在早期或临床前AD中可能具有治疗性预防价值.
关键词: 阿尔茨海默病,氧化应激,炎症,微量锂,小胶质细胞,TREM 2。
Current Alzheimer Research
Title:Microdose Lithium NP03 Diminishes Pre-Plaque Oxidative Damage and Neuroinflammation in a Rat Model of Alzheimer’s-like Amyloidosis
Volume: 15 Issue: 13
关键词: 阿尔茨海默病,氧化应激,炎症,微量锂,小胶质细胞,TREM 2。
摘要: Background: Microdose lithium is protective against Alzheimer’s disease (AD), although the precise mechanisms through which its protective effects are conferred remain unclear.
Objective: To further examine the effects during the earliest stages of Aβ pathology, we evaluated whether NP03, a microdose lithium formulation, modulates Aβ-mediated oxidative damage and neuroinflammation when applied to a rat transgenic model of AD-like amyloidosis overexpressing amyloid precursor protein (APP).
Method: McGill-R-Thy1-APP transgenic rats and wild-type littermates were treated with NP03 or vehicle formulation for 8 weeks beginning at 3 months of age - a phase preceding Aβ plaque deposition in the transgenic rats.
Results: Oxidative and nitrosative stress markers, protein-bound 4-hydroxynonenal (HNE) and proteinresident 3-nitrotyrosine (3-NT), inflammatory cytokines production, as well as microglial recruitment towards Aβ-burdened neurons were assayed. NP03 significantly decreased cerebral HNE and 3-NT, and reduced production of pro-inflammatory cytokines in McGill-R-Thy1-APP transgenic rats. NP03 further reduced expression of microglia surface receptor Trem2 and led to a corresponding reduction in microglia recruitment towards Aβ-burdened neurons in the CA1 region of the hippocampus.
Conclusion: These results suggest that NP03 may function to slow the AD-like pathology in part by modifying oxidative/nitrosative damage and neuroinflammation, raising the possibility that low doses of microencapsulated lithium might be of therapeutic-preventive value during very early or preclinical AD.
Export Options
About this article
Cite this article as:
Microdose Lithium NP03 Diminishes Pre-Plaque Oxidative Damage and Neuroinflammation in a Rat Model of Alzheimer’s-like Amyloidosis, Current Alzheimer Research 2018; 15 (13) . https://dx.doi.org/10.2174/1567205015666180904154446
DOI https://dx.doi.org/10.2174/1567205015666180904154446 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Safety of Gene Therapy: New Insights to a Puzzling Case
Current Gene Therapy Experimental Benefits of Sex Hormones on Vascular Function and the Outcome of Hormone Therapy in Cardiovascular Disease
Current Cardiology Reviews Microsomal Prostaglandin E2 Synthase-1 as a New Macromolecular Drug Target in the Prevention of Inflammation and Cancer
Anti-Cancer Agents in Medicinal Chemistry Preface [Hot Topic: Antimycobacterial Drugs: Current Status and Future Prospects (Executive Editor: Haruaki Tomioka)]
Current Pharmaceutical Design The Antimicrobial Peptide LL-37 Inhibits HIV-1 Replication
Current HIV Research Chromosomal Translocations as Biomarkers in Leukemia Diagnosis and Pharmacogenomics
Recent Patents on Biomarkers Synthetic Peptide Mimics of the Bowman-Birk Inhibitor Protein
Current Medicinal Chemistry Microglia-Neuron Interaction in Inflammatory and Degenerative Diseases: Role of Cholinergic and Noradrenergic Systems
CNS & Neurological Disorders - Drug Targets Bacterial Zinc Proteases and their Inhibition
Current Enzyme Inhibition Mechanisms of Drug Resistance in Cancer Chemotherapy: Coordinated Role and Regulation of Efflux Transporters and Metabolizing Enzymes
Current Pharmaceutical Design Efficacy of Anti-TNF in Crohns Disease: How Does it Work?
Current Drug Targets Role of Stromal-Derived Factor-1 in Mesenchymal Stem Cell Paracrinemediated Tissue Repair
Current Stem Cell Research & Therapy Baculovirus as Vaccine Vectors
Current Gene Therapy Current Drug Targets for Antihyperlipidemic Therapy
Mini-Reviews in Medicinal Chemistry Modulation of Immuno-biome during Radio-sensitization of Tumors by Glycolytic Inhibitors
Current Medicinal Chemistry Sole Anti-inflammatory Immunomodulators: Innovative Drugs to Prevent and Treat Autoimmune Diseases and Proteopathies
Current Chinese Science Molecular Chaperone Disorders: Defective Hsp60 in Neurodegeneration
Current Topics in Medicinal Chemistry Drug Nanocarriers and Functional Nanoparticles: Applications in Cancer Therapy
Current Drug Delivery Homeostasis and Compensatory Homeostasis: Bridging Western Medicine and Traditional Chinese Medicine
Current Cardiology Reviews Pharmacological Applications of Diphenylamine and Its Derivative as Potent Bioactive Compound: A Review
Current Bioactive Compounds